HealthStream (NASDAQ:HSTM) Lowered to Sell at Zacks Investment Research
Zacks Investment Research lowered shares of HealthStream (NASDAQ:HSTM) from a hold rating to a sell rating in a research report sent to investors on Wednesday, January 3rd.
According to Zacks, “HealthStream is dedicated to improving patient outcomes through the development of healthcare organizations’ greatest asset: their people. Their unified suite of solutions is contracted by, collectively, over 4.5 million healthcare employees in the U.S. for workforce development, training & learning management, talent management, performance assessment, and managing simulation-based education programs. Their research solutions provide valuable insight to healthcare providers to meet HCAHPS requirements, improve the patient experience, engage their workforce, and enhance physician alignment. Their provider solutions offer healthcare providers innovative tools to support healthcare organizations in appropriately credentialing and privileging their workforce. “
Several other analysts have also issued reports on the stock. Needham & Company LLC restated a hold rating and set a $26.00 target price on shares of HealthStream in a research report on Tuesday, October 24th. ValuEngine raised shares of HealthStream from a sell rating to a hold rating in a report on Wednesday, January 3rd. Canaccord Genuity reaffirmed a hold rating and set a $25.00 price target on shares of HealthStream in a report on Monday, October 23rd. Finally, Robert W. Baird lowered their price target on shares of HealthStream from $30.00 to $28.00 and set an outperform rating on the stock in a report on Wednesday, October 25th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and two have assigned a buy rating to the stock. The stock presently has an average rating of Hold and an average price target of $24.83.
HealthStream (NASDAQ:HSTM) last announced its earnings results on Monday, October 23rd. The technology company reported $0.08 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.05 by $0.03. The company had revenue of $63.60 million during the quarter, compared to analyst estimates of $62.48 million. HealthStream had a net margin of 2.36% and a return on equity of 2.46%. The firm’s quarterly revenue was up 8.9% compared to the same quarter last year. During the same period in the previous year, the business posted $0.04 earnings per share. analysts forecast that HealthStream will post 0.23 earnings per share for the current fiscal year.
Hedge funds have recently added to or reduced their stakes in the company. Stevens Capital Management LP bought a new position in HealthStream during the third quarter valued at $367,000. BNP Paribas Arbitrage SA increased its position in HealthStream by 65.6% during the third quarter. BNP Paribas Arbitrage SA now owns 13,466 shares of the technology company’s stock valued at $315,000 after acquiring an additional 5,335 shares during the last quarter. FMR LLC increased its position in HealthStream by 2.5% during the second quarter. FMR LLC now owns 4,733,510 shares of the technology company’s stock valued at $124,586,000 after acquiring an additional 116,309 shares during the last quarter. Cornerstone Capital Management Holdings LLC. bought a new position in HealthStream during the third quarter valued at $448,000. Finally, Algert Global LLC bought a new position in HealthStream during the third quarter valued at $1,948,000. 75.31% of the stock is currently owned by hedge funds and other institutional investors.
HealthStream Company Profile
HealthStream, Inc (HealthStream) provides workforce, patient experience and provider solutions for healthcare organizations. The Company operates in three segments: HealthStream Workforce Solutions, HealthStream Patient Experience Solutions and HealthStream Provider Solutions. HealthStream’s products and services are organized into three segments: Workforce Solutions, Patient Experience Solutions, and Provider Solutions.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for HealthStream Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthStream and related companies with MarketBeat.com's FREE daily email newsletter.